Abstract
Background. Proteinuria is a cardinal feature of glomerular disease, including diabetic nephropathy, and the glomerular filtration barrier acts as a filter, restricting protein excretion in urine. We tested whether the expression of P-cadherin, a molecule known to be located at the slit diaphragm, was altered by diabetes in vivo and by high glucose in vitro. Methods. In vivo, 24 Sprague-Dawley rats were injected with diluent [control (C), n=8] or streptozotocin intraperitoneally and the latter were left untreated (DM, n=8) or treated with insulin (DM+I, n=8) for 6 weeks. In vitro, immortalized mouse podocytes were cultured in media with 5.6 mM glucose (LG), LG + 19.4 mM mannitol (LG + M) or 25 mM glucose (HG) with or without protein kinase C (PKC) inhibitor (10-7M calphostin C or 10-6 M GF 109203X). Reverse transcription-polymerase chain reaction, western blotting for P-cadherin mRNA and protein expression, respectively, were performed with sieved glomeruli and cell lysates, and immunofluorescence staining was undertaken with renal tissue. Results. Twenty-four hour urinary albumin excretion was significantly higher in DM compared with C and DM+I rats (P<0.05). Glomerular P-cadherin mRNA expression was significantly lower in DM (1.36±0.20 × 10-2 attm/ng RNA) than in C rats (2.61±0.33 × 10-2 attm/ng RNA) (P<0.05). P-Cadherin protein expression, assessed by western blot and immunofluorescence staining, was also decreased in DM compared with C and DM+I glomeruli. HG significantly reduced P-cadherin mRNA and protein expression in cultured podocytes by 42% and 62%, respectively (P<0.05), and these decrements were ameliorated by PKC inhibitor. Conclusions. Diabetes in vivo and exposure of podocytes to HG in vitro reduced P-cadherin mRNA and protein expression, and PKC was involved in the regulation of HG-induced down-regulation of P-cadherin. These findings suggest that the decrease in P-cadherin expression is connected with the early changes of diabetic nephropathy and, thus, may contribute to the development of proteinuria.
| Original language | English |
|---|---|
| Pages (from-to) | 524-531 |
| Number of pages | 8 |
| Journal | Nephrology Dialysis Transplantation |
| Volume | 20 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - 2005 Mar 1 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Nephrology
- Transplantation
Cite this
}
P-cadherin is decreased in diabetic glomeruli and in glucose-stimulated podocytes in vivo and in vitro studies. / Xu, Zhong Gao; Ryu, Dong Ryeol; Yoo, Tae Hyun; Jung, Dong Sub; Kim, Jin Ju; Kim, Hyung Jong; Choi, Hoon Young; Kim, Joo Seong; Adler, Sharon G.; Natarajan, Rama; Han, Dae Suk; Kang, Shin Wook.
In: Nephrology Dialysis Transplantation, Vol. 20, No. 3, 01.03.2005, p. 524-531.Research output: Contribution to journal › Article
TY - JOUR
T1 - P-cadherin is decreased in diabetic glomeruli and in glucose-stimulated podocytes in vivo and in vitro studies
AU - Xu, Zhong Gao
AU - Ryu, Dong Ryeol
AU - Yoo, Tae Hyun
AU - Jung, Dong Sub
AU - Kim, Jin Ju
AU - Kim, Hyung Jong
AU - Choi, Hoon Young
AU - Kim, Joo Seong
AU - Adler, Sharon G.
AU - Natarajan, Rama
AU - Han, Dae Suk
AU - Kang, Shin Wook
PY - 2005/3/1
Y1 - 2005/3/1
N2 - Background. Proteinuria is a cardinal feature of glomerular disease, including diabetic nephropathy, and the glomerular filtration barrier acts as a filter, restricting protein excretion in urine. We tested whether the expression of P-cadherin, a molecule known to be located at the slit diaphragm, was altered by diabetes in vivo and by high glucose in vitro. Methods. In vivo, 24 Sprague-Dawley rats were injected with diluent [control (C), n=8] or streptozotocin intraperitoneally and the latter were left untreated (DM, n=8) or treated with insulin (DM+I, n=8) for 6 weeks. In vitro, immortalized mouse podocytes were cultured in media with 5.6 mM glucose (LG), LG + 19.4 mM mannitol (LG + M) or 25 mM glucose (HG) with or without protein kinase C (PKC) inhibitor (10-7M calphostin C or 10-6 M GF 109203X). Reverse transcription-polymerase chain reaction, western blotting for P-cadherin mRNA and protein expression, respectively, were performed with sieved glomeruli and cell lysates, and immunofluorescence staining was undertaken with renal tissue. Results. Twenty-four hour urinary albumin excretion was significantly higher in DM compared with C and DM+I rats (P<0.05). Glomerular P-cadherin mRNA expression was significantly lower in DM (1.36±0.20 × 10-2 attm/ng RNA) than in C rats (2.61±0.33 × 10-2 attm/ng RNA) (P<0.05). P-Cadherin protein expression, assessed by western blot and immunofluorescence staining, was also decreased in DM compared with C and DM+I glomeruli. HG significantly reduced P-cadherin mRNA and protein expression in cultured podocytes by 42% and 62%, respectively (P<0.05), and these decrements were ameliorated by PKC inhibitor. Conclusions. Diabetes in vivo and exposure of podocytes to HG in vitro reduced P-cadherin mRNA and protein expression, and PKC was involved in the regulation of HG-induced down-regulation of P-cadherin. These findings suggest that the decrease in P-cadherin expression is connected with the early changes of diabetic nephropathy and, thus, may contribute to the development of proteinuria.
AB - Background. Proteinuria is a cardinal feature of glomerular disease, including diabetic nephropathy, and the glomerular filtration barrier acts as a filter, restricting protein excretion in urine. We tested whether the expression of P-cadherin, a molecule known to be located at the slit diaphragm, was altered by diabetes in vivo and by high glucose in vitro. Methods. In vivo, 24 Sprague-Dawley rats were injected with diluent [control (C), n=8] or streptozotocin intraperitoneally and the latter were left untreated (DM, n=8) or treated with insulin (DM+I, n=8) for 6 weeks. In vitro, immortalized mouse podocytes were cultured in media with 5.6 mM glucose (LG), LG + 19.4 mM mannitol (LG + M) or 25 mM glucose (HG) with or without protein kinase C (PKC) inhibitor (10-7M calphostin C or 10-6 M GF 109203X). Reverse transcription-polymerase chain reaction, western blotting for P-cadherin mRNA and protein expression, respectively, were performed with sieved glomeruli and cell lysates, and immunofluorescence staining was undertaken with renal tissue. Results. Twenty-four hour urinary albumin excretion was significantly higher in DM compared with C and DM+I rats (P<0.05). Glomerular P-cadherin mRNA expression was significantly lower in DM (1.36±0.20 × 10-2 attm/ng RNA) than in C rats (2.61±0.33 × 10-2 attm/ng RNA) (P<0.05). P-Cadherin protein expression, assessed by western blot and immunofluorescence staining, was also decreased in DM compared with C and DM+I glomeruli. HG significantly reduced P-cadherin mRNA and protein expression in cultured podocytes by 42% and 62%, respectively (P<0.05), and these decrements were ameliorated by PKC inhibitor. Conclusions. Diabetes in vivo and exposure of podocytes to HG in vitro reduced P-cadherin mRNA and protein expression, and PKC was involved in the regulation of HG-induced down-regulation of P-cadherin. These findings suggest that the decrease in P-cadherin expression is connected with the early changes of diabetic nephropathy and, thus, may contribute to the development of proteinuria.
UR - http://www.scopus.com/inward/record.url?scp=20144381750&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=20144381750&partnerID=8YFLogxK
U2 - 10.1093/ndt/gfh642
DO - 10.1093/ndt/gfh642
M3 - Article
C2 - 15647309
AN - SCOPUS:20144381750
VL - 20
SP - 524
EP - 531
JO - Nephrology Dialysis Transplantation
JF - Nephrology Dialysis Transplantation
SN - 0931-0509
IS - 3
ER -